I join my colleagues in welcoming all of our witnesses today. It has been a fascinating discussion. I, too, have been looking forward to today's session.
Eight minutes goes by in a hurry, so I'll be brief in the hope that each of you might support me and be brief as well so we can get through a few questions. I may be a little overly aggressive here, trying to do too much.
Madam Gagné and Ms. Vollmerhausen, I wonder if you could speak briefly to the cost structure. You mentioned the cost of the particular prosthetic that you demonstrated. What was the timeline, the cost structure and the engineering that was ingrained in the development of that product? Can you give us an idea? How did that change from the status quo?